Elide Anna Pastorello

Elide Anna Pastorello

Auto-generated profile, based on publicly available information

Elide Anna Pastorello

Unit of Allergology and Immunology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy,

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
PMP. M. Matricardi
P. M. Matricardi
JKJ. Kleine‐Tebbe
J. Kleine‐Tebbe
HHH. J. Hoffmann
H. J. Hoffmann
RVR. Valenta
R. Valenta
Christiane HilgerChristiane Hilger
Christiane Hilger
MOM. Ollert
M. Ollert
The availability of allergen molecules (‘components’) from several protein families has advanced our understanding of immunoglobulin E (IgE)‐mediated responses and enabled ‘component‐resolved diagnosis’ (CRD). The European Academy of Allergy and Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) provides comprehensive information on important allergens and describes the diagnostic options usingCRD. Part A of theEAACI MAUGintroduces allergen molecules, families, composition of extracts, databases, and diagnostic IgE, skin, and basophil tests. Singleplex and multiplex IgE assays with components improve both sensitivity for low‐abundance allergens and analytical specificity; IgE to individual allergens can yield information on clinical risks and distinguish cross‐reactivity from true primary sensitization. Part B discusses the clinical and molecular aspects of IgE‐mediated allergies to foods (including nuts, seeds, legumes, fruits, vegetables, cereal grains, milk, egg, meat, fish, and shellfish), inhalants (pollen, mold spores, mites, and animal dander), and Hymenoptera venom. Diagnostic algorithms and short case histories provide useful information for the clinical workup of allergic individuals targeted forCRD. Part C covers protein families containing ubiquitous, highly cross‐reactive panallergens from plant (lipid transfer proteins, polcalcins,PR‐10, profilins) and animal sources (lipocalins, parvalbumins, serum albumins, tropomyosins) and explains their diagnostic and clinical utility. Part D lists 100 important allergen molecules. In conclusion, IgE‐mediated reactions and allergic diseases, including allergic rhinoconjunctivitis, asthma, food reactions, and insect sting reactions, are discussed from a novel molecular perspective. TheEAACI MAUGdocuments the rapid progression of molecular allergology from basic research to its integration into clinical practice, a quantum leap in the management of allergic patients.

1 March 2023 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
SDStephanie Dramburg
Stephanie Dramburg
Christiane HilgerChristiane Hilger
Christiane Hilger
ASAlexandra F Figueira Santos
Alexandra F Figueira Santos
LVLeticia de las Vecillas
Leticia de las Vecillas
RARob C. Aalberse
Rob C. Aalberse
KHKarin Hoffmann-Sommergruber
Karin Hoffmann-Sommergruber
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowledge about the immunological mechanisms of IgE‐mediated allergies has remarkably increased. In addition to understanding the immune response and clinical symptoms, allergy diagnosis and management depend strongly on the precise identification of the elicitors of the IgE‐mediated allergic reaction. In the past four decades, innovations in bioscience and technology have facilitated the identification and production of well‐defined, highly pure molecules for component‐resolved diagnosis (CRD), allowing a personalized diagnosis and management of the allergic disease for individual patients. The first edition of the “EAACI Molecular Allergology User's Guide” (MAUG) in 2016 rapidly became a key reference for clinicians, scientists, and interested readers with a background in allergology, immunology, biology, and medicine. Nevertheless, the field of molecular allergology is moving fast, and after 6 years, a new EAACI Taskforce was established to provide an updated document. The Molecular Allergology User's Guide 2.0 summarizes state‐of‐the‐art information on allergen molecules, their clinical relevance, and their application in diagnostic algorithms for clinical practice. It is designed for both, clinicians and scientists, guiding health care professionals through the overwhelming list of different allergen molecules available for testing. Further, it provides diagnostic algorithms on the clinical relevance of allergenic molecules and gives an overview of their biology, the basic mechanisms of test formats, and the application of tests to measure allergen exposure.

1 March 1989 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
COC. Ortolani
C. Ortolani
MIM. Ispano
M. Ispano
EPE.A. Pastorello
E.A. Pastorello
RAR. Ansaloni
R. Ansaloni
GMG.C. Magri
G.C. Magri

1 November 2008 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GPGabrielle Pauli
Gabrielle Pauli
TLTina H. Larsen
Tina H. Larsen
SRSabina Rak
Sabina Rak
FHFriedrich Horak
Friedrich Horak
EPElide Pastorello
Elide Pastorello
HMHans-Jorgen Malling
Hans-Jorgen Malling

1 September 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
HMHolger Mosbech
Holger Mosbech
RDRegina Deckelmann
Regina Deckelmann
FBFréderic de Blay
Fréderic de Blay
EPElide Anna Pastorello
Elide Anna Pastorello
ETEwa Trebas-Pietras
Ewa Trebas-Pietras
Giorgio Walter CanonicaGiorgio Walter Canonica
Giorgio Walter Canonica

1 March 1999 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
EPElide A. Pastorello
Elide A. Pastorello
LFLaura Farioli
Laura Farioli
VPValerio Pravettoni
Valerio Pravettoni
COClaudio Ortolani
Claudio Ortolani
MIMarco Ispano
Marco Ispano
ACAmedeo Conti
Amedeo Conti